Axsome Therapeutics, Inc. AXSM 深 沪
等待开盘 02-06 09:30:00 美东时间
180.84
-4.700
-2.53%
华盛通- 最 高188.445
- 今 开185.42
- 成交量 89.15万股
- 最 低 180.02
- 昨 收 185.54
- 总市值 91.17亿
- 52周最高 191.50
- 市盈率 静 --
- 换手率 1.77%
- 52周最低 86.99
- 委 比 -6.25%
- 总股本 5041.26万
- 历史最高 191.50
- 量 比 1.33
- 振 幅 4.54%
- 历史最低 1.94
- 每 手 1
- 风险率 22.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp
U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp Feb 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adobe, Exxon Mobil and Stellar Bancorp, on Tuesday. HIGHLIGHTS * Adobe ADBE.O : Piper Sandler cuts to neutra
02-03 16:27
Axsome Therapeutics CEO Herriot Tabuteau Reports Disposal of Common Shares
Axsome Therapeutics CEO Herriot Tabuteau Reports Disposal of Common Shares Herriot Tabuteau, Chief Executive Officer of Axsome Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created b
02-03 07:30
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth
U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth Jan 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Boeing, Carvana and UnitedHealth on Wednesday. HIGHLIGHTS * Boeing BA.N : JP Morgan raises target price to $270
01-28 15:23
Axsome Therapeutics CFO Nick Pizzie Reports Sale of Common Shares
Axsome Therapeutics CFO Nick Pizzie Reports Sale of Common Shares Nick Pizzie, Chief Financial Officer of Axsome Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technolog
01-24 08:00
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX
U.S. RESEARCH ROUNDUP-IBM, KLA, WEX Jan 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, KLA and WEX, on Wednesday. HIGHLIGHTS * IBM IBM.N : JP Morgan raises target price to $312 from $290 * KLA Corp KLAC.O : Deut
01-21 16:26
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
HC Wainwright & Co. Maintains Buy on Axsome Therapeutics, Raises Price Target to $260
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Axsome Therapeutics (NASDAQ:AXSM) with a Buy and raises the price target from $200 to $260.
01-20 19:57
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
美股大行评级 | 高盛上调谷歌目标价从330美元升至375美元；5家大行集体上调Five Below目标价最高至255美元
今日重点评级关注：HC Wainwright & Co.：维持NioCorp Developments"买入"评级，目标价从9.5美元升至11.25美元；摩根士丹利：维持Chewy"超配"评级，目标价从48美元升至51美元
01-14 11:25
